Abstract: Peptide-based nanoparticles (pep-NPs) are emerging as promising imaging and therapeutic agents against cancer due to their biocompatibility and tunability. Optimized design of the peptide sequence and moderate conjugation of the sequence with extraneous molecules are crucial to the performance of the inherent properties of pep-NPs such as nanostructure formation and ability of drug delivery. Meanwhile, the peptide sequences based on natural/unnatural amino acids could be utilized for designing nanostructures susceptive/resistant to specific enzymes. Herein, we firstly summarize the basic peptide structures to provide a whole image of pep-NPs. Subsequently, the diagnostic strategies based on different imaging modalities and recent therapeutic applications of pep-NPs for cancer are reviewed.
INTRODUCTION
Scientists have long been imaging doctors using peptidebased nanomaterials to stop bleeding, regenerate severed nerves, or kill cancer cells in clinics. Nanotechnology is regarded as "foreseeable to offer personalized diagnostic tools and treatment in the future, especially for treating cancer." In the "bottom-up" strategy of building nanostructures for cancer diagnosis or therapy, peptide-based nanoparticles (pepNPs) are emerging in recent years as one of the most sophisticated, green structures with numerous advantages over other organic or inorganic nanoparticles (NPs). Herein we start with the introduction of the most commonly used peptide structures for the preparation of pep-NPs. Then we introduced the systematic strategies of designing pep-NPs for cancer diagnosis and therapy in recent five years.
PEPTIDE-BASED NANOPARTICLES

Introduction
Basically, pep-NPs could be attained by constructing single peptide or oligomeric polypeptides into certain morphological structure via non-covalent interactions including ionic or hydrophobic interactions, hydrogen bonding, andstacking. Specific configurations could be obtained such as nanofibers, nanotapes, or nanoribbons in one dimension (1D); hydrogel networks in two dimensions (2D); and scaffolds in three dimensions (3D) if the peptide sequences are delicately modulated. The reasons that pep-NPs are the favorites of chemists to design nanostructures for in vivo applications lie in their numerous advantages over other inorganic or organic nanostructures due to their exceptional inherent properties listed below. 1) Biocompatibility and biode-gradability: Leading to a minimized toxicity to normal cells; 2) The ability of self-assembly: Based on the interactions between first order motifs, peptide chains have the ability to form secondary structures such as associating of -strands, the coiling of helices [1] . For instance, peptides withstrands could assemble into one-dimensional nanostructures via intermolecular hydrogen bonding. Furthermore, this 1D structure could lead to the construction of 2D -sheets, or further 3D network under inter-sheets interactions [2] ; 3) Processibility of engineering: After the sequence being delicately adjusted or incorporated with extraneous molecules, pep-NPs are able to form bioactive hydrogels as mimicries for native extracellular matrix (ECM) and large proteins. The hydrogels can also functionalize as vehicles for drug transportation [3, 4] ; 4) Responsive to stimulus: Pep-NPs and their derivatives have unique characteristics for the ability of responding to certain environmental stimulations such as pH changes, thermal differences, as well as biological activations (e.g., overexpression of some enzymes) [1] . 5) Structural morphological specificity: Pep-NPs are programmable. Highly specific ligands have been demonstrated able to precisely control the morphology of the particle through the biotic/abiotic interface. Researchers have employed pep-NPs as templates for designing other materials [5] , such as Pd nanoparticles [6] .
With these above-mentioned properties, pep-NPs have been widely used in the fields of engineering, chemical biology, material science, etc. Besides the applications of cell imaging and drug delivery reviewed herein, using pep-NPs as biomaterials for other applications can be referred from recent reviews [7] .
-helix/Coiled Coils
Firstly reported by Pauling, Corey, and Crick [8, 9] , -helix has been used as one common component for selfassembling fibrous structures. -helix is a right-handed coiled conformation where every backbone NH group donates a Hbond to the carbonyl group of the amino acid 4 residues earlier at the backbone. Coiled-coil -helices are highly stable configurations where two or more helices wrap around each other in a "supercoil" structure. Heptad Repeat, in which coiled coils are highly characteristic, have a repeated seven residues, labeled from a to g, where the 1 st and the 4 th (or a and d) residues are always hydrophobic and could pack together in the interior of the helix bundle. In the mean time, the 5 th and the 7 th residues (or e and g) have opposite charges and form a salt bridge stabilized by electrostatic interactions. In this way, coiled coils contain at least 2 helices to form a hydrophobic interface, which drives the system into selfassembly. Deming reported a new artificial peptide for selfassembling hydrogel, in which the amphiphilic block copolypeptides self-assemble via the non-covalent interactions among the hydrophobic -helical domains. The chain length of the peptide are tunable by changing the numbers of amino acids in both the polyelectrolyte domain (e.g., poly(L-lysine, (K)) or poly(L-glutamate, (E)) and the hydrophobic domain (e.g., poly(L-leucine, (L)) (see Fig. 1A ). Peptides of different K m L n or E m L n (m, n represent the numbers of amino acids) could have different properties in solution. Within the peptides studied, some could self-assemble into hydrogels with 1D fibrous structure or 2D membrane structure (see Fig. 1B ) [10] . Interestingly, the packing patterns of the peptide as well as the mechanical properties of the hydrogel could be delicately adjusted by sequence design of the peptide [1] . This system has been widely used in the fields of tissue engineering, drug delivery, etc. 
-Sheets and -Hairpins
-Sheets are those structures consist of multiple peptide chains to form the extended backbone arrangement via the hydrogen bonding among the backbone amides and carbonyls. H-bonds strand the peptide chains into sheet-structures. -sheets are classified into two types (parallel or anti-parallel) by whether the C-terminus are at the same end of the structure or not which impacts the interactions among the sheets seriously [11] . Most of -Sheets are prone to self-assemble into 1D fibrous structure via the delicate adjustment of amphiphilicity of the peptide. For -Sheets to self-assemble higher order structures (see Fig. 2 ), concentration of monomer peptide and ionic strength in the system always impact.
Fig. (2).
-sheet based fibers can form a series of hierarchical structures in a concentration dependent manner. (a) basic peptide structure, as a monomer (b), which assembles into tape (c, c'), two of which can bury hydrophobic residues by forming a ribbon (d, d'), further assemble by lying face to face to form fibrils (e, e'), additionally side by side to form fibers (f, f') [11] .
-hairpins are formed with two short -sheet sequences linked by a turn sequence. Pochan and Schneider reported a -hairpin peptide hydrogel in 2008. In brief, the twenty amino acid parent peptide MAX1, which contains two strands of alternating valines and lysines, functionalizes assheets. Residues flanking through a central tetrapeptide type II' -turn region (VKVKVKVKV D PPTKVKVKVKVKV-NH 2 ) take a random coil conformation at pH 7.4 and low ionic strength via the electrostatic repulsion between the positively-charged lysine residues (Fig. 3) . At higher pH value and ionic strength, the charges on lysine residues of the peptide are screened resulting in the amphiphilic -hairpin conformation. Subsequently, the folded hairpins selfassemble into fibrillar nanostructure via intermolecular Hbonds. This structure was reported as excellent 2D or 3D scaffolds for cell growth and proliferation [12] .
Peptide Amphiphiles
There are two types of peptide amphiphiles (PAs). One is oligomeric polypeptides modified with hydrophobic alkyl tails. This type of PAs have both hydrophobic and hydrophilic ends separated. The other type of PAs contain different components with different affinities conjugating together. The multiplicities of PAs enable them as templates to synthesize multifunctional advanced nanostructures (e.g., silica nanotubes [13] ). For example, PAs can be used to conjugate with imaging motifs while their topologic structures remain unchanged. Woolfson and co-workers reported the modification of self-assembling peptide fibers (SAFs) with biotin or rhodamine-B tags and proved the good stability of the fibers against washing [14] .
PAs as drug delivery systems at nano-scale can effectively enhance the cellular permeability of those drugs which cannot be efficiently internalized by cells. 
Aromatic Short Peptide Derivatives
Until now, many articles have reported that diphenylalanine can act as the core sequences of some amyloid peptides which are able to self-assemble into pep-NPs. Both the fundamental research and the applications of diphenylalanine-based pep-NPs have been widely explored [16, 17] . What's more, aromatic groups such as fluorenylmethoxycarbonyl (Fmoc), carbobenzyloxy and naphthalene, are equally able to drive the self-assembly via -stacking when conjugating to short peptides. All of these pep-NPs have been thoroughly studied and tested as potential drug delivery systems [18] [19] [20] .
Chauhan's group had observed that aromatic residue containing short peptides even dipeptides could self-assemble into nanotubes and nanovesicles. In addition, they also found that E-F and K-F (here , -dehydrophenyalanine is denoted as F) are resistent to nonspecific protease treatment. Based on these observations, they designed the two amphiphilic dipeptides, H-E-F-OH and NH 2 -K-F-COOH, which could self-assemble into stable spherical structures (see Fig. 4 ). These vesicles could load various drugs at high encapsulation rate, such as hemin at encapsulation rates of 56% (w/w) or 60% (w/w). When incubated with HeLa cells for 4-24 h, the nanovesicles are readily internalized by the cells and no observable cytotoxicity is induced, suggesting the nanovesicles could have potential applications as novel delivery systems [21] . Fig. (3) . The self-assembly mechanism for MAX8. Addtion of the trigger (20 mM BTM, 150 nM NaCl, pH 7.4) to the unfolded peptide solution drives the unfolded peptide to adopt a -hairpin conformation. Numerous hairpins assemble laterally, primarily due to hydrogen bonding, and facially, due to hydrophobic collapse, into monodispersed fibrillar nanostructure. Multiple fibrils form a network, leading to hydrogel formation [12] . Ulijn et al. reported an enzyme-assisted self-assembly system using aromatic peptides, Fmoc-F and Fmoc-L, and studied the process of thermodynamic equilibrium of the self-assembly. A non-specific endoprotease (i.e., thermolysin) was used to trigger the peptide bond formation and reversed hydrolysis. An obvious nano-structural change from fibers to sheets, as well as the percentage composition change from Fmoc-F 3 domination to Fmoc-F 5 domination, could be observed through time course (Fig. 5) . Moreover, they also studied the kinetics of this enzymatic self-assembly by monitoring the enzyme-assisted structural nucleation and growth. They modified the thermolysin with a di-amino PEG and used Congo Red to visualize structure formation. Association of the dye with the -sheet of the fibers results in green birefringence and no effect would be observed on the regions without enzyme [22] .
Stimuli-Responsive Assembly/Disassembly of Pep-NPs
People can take the advantage of the stimuli-responsive property of peptides to trigger their self-assemblies for biomedical applications such as transferring, cumulating imaging agents or drugs. These stimuli in vitro or in vivo include overexpression of certain enzymes, pH, ionic strength, light, sound, etc.
pH
The pH trigger usually controls the protonation or deprotonation of a peptide. Consequently, change of polarity of the peptide triggers the assembly/disassembly of the peptide and constructs/destructs the nanostructures in the end. So-called pH-induced self-assembly has been a conventional method of developing novel nanomaterials with well-defined stable structure, such as organic nanofiber-inorganic nanoparticle hybrid nanocomposites [23] . The pH control could be achieved through several methods. For example, Kim and Lee conjugated the tumor-targeting peptide, AP peptide, with pH-responsive polymeric micelles and loaded the micelles with anticancer drug, doxorubicin (DOX) (Fig. 6) . Both in vivo and in vitro, the tumor-targeted polymeric micelles (AP-PEG-PLA) exhibited a sharp pH-responsive micellization/demicellization transition and excellent drug release profile [24] .
Enzymes
Enzymes are always introduced in those systems that enzyme triggers non-assembling precursors into selfassembling monomers, thus in situ forming nanostructures at the locations of the enzymes (e.g. in tumors where the enzyme overexpresses). There are some reviews highlighting enzymatic controlled self-assembly of small molecules to form hydrogels both in vivo and in vitro [25] . Here in Table 1 we summarized the enzymes or proteases that most widely used as triggers for initiating the self-assembly of nanostructures for tumor diagnosis or therapy. 
Light
The rising demands of non-invasive or minimally invasive therapeutic methods for cancer call for rapid development of medical technologies such as radiation therapy, ultrasound treatment, cryotherapy, and photodynamic therapy (PDT) [31] . As a light-activated treatment modality, PDT kills cancer cells by exciting the photosensitizers (PS) with an appropriate wavelength of light. Due to the poor or limited water solubility, PS always needs appropriate structures as its carriers for selectively accumulating in malignant cells and co-localizing the light irradiation to avoid damaging healthy tissues. These demands inspire people to construct soft biological structures which are thermal responsive.
Verma and co-workers constructed a conjugate, a C 3 -symmetric ditryptophan-tren derivative conjugating to 3-mercaptopropionic acid, which could self-assemble into spherical structures through -stacking. Due to the existence of thiol group, as-formed spheres could capture gold nanoparticles (AuNPs) on their surfaces. Due to the surface plasmon resonance (SPR) effect, the AuNPs on the spheres could absorb sunlight and induce the decomposition of the spheres within 2 hours. To directly observe this process, they loaded the sphere with rhodamine-B and subsequently incubated the sphere composite with AuNPs, then directly exposed the spheres to 6-hour sunlight and imaged with a fluorescence microscope (Fig. 7) . The results indicated that such hybrid structures might be a potential light-induced drug delivery platform [32] .
PEP-NPS FOR CANCER DIAGNOSIS AND THER-APY
Introduction
Cancer diagnosis and therapy are two main stages for clinical treatment of cancer. Drugs and methods used for these two stages are commonly facing with some basic advantages, disadvantages, as well as requirements. Nowadays, there is a trend of "theranostics", which combines diagnostic and therapeutic modalities within one so as to develop individually designed therapies and accomplish diagnosis in the same time [33] . In this article, we firstly discussed the general properties of pep-NPs for cancer diagnosis or therapy, followed by the discussions of specific properties of each pep-NPs case by case.
Pep-NPs have extraordinary advantages over other materials (e.g., small molecule) on cancer diagnosis and therapy. Firstly, pep-NPs have high biocompatibility and biodegradability [34] ; Secondly, pep-NPs with 10-500 nm sizes, could remain in the circulation for an extended period of time [35] . Another advantage of pep-NPs is the size-effect on tumors called Enhanced Permeation and Retention (EPR) Effect, which is because tumors usually have a rapid construction of new, fenestrated vascular structure and thus are more vulnerable than normal tissues to nanoparticles. EPR effect offers pep-NPs with the advantages for passive tumor-targeting as drugs or imaging agents [36] ; Thirdly, peptides could act as targeting molecules themselves due to their intrinsic selectivities. Techniques, such as phage display [37] , could be used to screen highly selective targeting peptides to target certain small molecules [38] or specific biomarkers for certain tissue/organ functions [39] . Lastly, low cost, high stability, Targeted drug delivery [26] ; Enhanced agent accumulation [27] .
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simplicity for manufacturing of pep-NPs rank themselves on the top of the candidate list to construct nanosystems for cancer diagnosis and therapy. For a successful imaging or therapy of cancer, no rules existing could be applied as axioms. Nevertheless, there still exist some practical criteria reported by recent literatures as follows [40] . 1) Efficient delivery of the agents to the targeted places; 2) Biocompatibility and the ability of cellular translocation of the agents; 3) Immunogenicity issues. Some peptide sequences may induce immunogenic response and this should be reduced or avoided; 4) Using amplification strategies to elevate the local concentrations of the agents for imaging or therapy, thus maximize the "signal-to-noise" ratio (SNR) [41] ; 5) Specificity of the targeting agents to biomarkers to ensure a minimum dosage and side-effect [42] ; 6) Use of long-circulating modules/spacers to modify biologically active agents to achieve longer biological half-lives (retention time) and homogenous distribution in vivo. These criteria are also the essence of designing perfect pep-NPs for cancer diagnosis and therapy.
Peptide-Based Nanoparticles for Cancer Diagnosis
Diagnosis based on molecular imaging provides us with more detailed parameters of tumor, such as specific location, the premalignant molecular abnormalities, growth kinetics, and biomakers at molecular level [43, 44] . Peptide-based conjugates could be applied to most types of imaging modalities for tumor imaging. For instances, magnetic nanoparticles for magnetic resonance imaging (MRI), radioisotopes ( Tc) for position-emission tomography (PET) or single photon emission computed tomography (SPECT), micelles for ultrasound imaging [44] , iodide derivatives for computed tomography (CT), fluorophores for near-infrared (NIR), and quantum dots (QDs) for optical imaging can be conjugated to peptides via organic linkers. Recently, a lot of tumor-targeted pep-NPs probes, which are able to overcome in vivo barriers and concentrate locally to generate enough contrast for imaging, have been designed and reported.
Peptide-Tagged Nanoparticles for Cancer Diagnosis
There are a lot of works using nanoparticles tagged with peptides as cancer imaging probes. These tags could be roughly classified into two classes. In terms of their sources, one class of peptides are derived from affinity selections (e.g., phage display) and the other ones come from the modification of natural tags. When classified by their targets, one type of peptide tags directly target tumor biomarkers and the other ones target tumor-related systems (e.g., immune systems or nutrisystems). The mostly common tumor biomarkers for targeting are summarized in Table 2 . Generally, peptide-tagged nanoparticle probes could be constructed by fusing a tumor-targeting peptide, a linker, and the imaging moiety. Ideal pep-NPs probes should have high cellular uptake and enough period of retention in the tumor for imaging, together with low uptake in normal surrounding tissues so that the background signal is minimized.
In general, peptide ligands for binding receptors on tumor cells could be obtained with the three strategies following: employ of natural peptide ligands, optimization of natural peptides, and screening peptides from combinatorial peptide libraries [45] . Nowadays, those methods previously developed have been used as routine techniques, such as phage display peptide library [46] , spatially addressable parallel library [47] , synthetic library, affinity selection, and onebead one-compound (OBOC) combinational library [48] .
Radiolabelled Particles for Diagnosis
Having the advantages of high sensitivity and the concentration of its tracer low to picomolar, nuclear imaging has being widely applied in clinic for the detection of specific biomarkers, especially those in tumors. Peptides, precursors of pep-NPs, could be labeled with radioactive isotopes for nuclear imaging via a chelating moiety or a prosthetic group [58] . The most widely used chelating agents are branched chelators, such as diethylenetriaminepentaacetic acid (DTPA) and its analogues, macrocyclic chelators such as 1,4,7,10-tetra-azacyclododecane acid (DOTA) and its analogues. [63] . One of the main goals of nuclear imaging for chemists is to design/synthesize chelators with high stability in vivo so that the nuclides are more unlikely demetalated from the chelators. Guerin et al., for example, reported several bifunctional chelates (BFCs), DOTA-, NOTA-(1,4,7-triazacyclononane-1,4,7-triacetic acid), PCTA-(3,6,9,15-tetraazabicyclo[9.3.1]penta-deca-1(15),11,13-triene-3,6,9-triacetic acid), and Oxo-DO3A-(l-oxa-4,7,10-triazacyclododecane-4,7,10-triacetic acid) which are highly stable in vivo. After conjugating to peptides targeting GRP receptors and being labeled with 64 Cu, those chelates were successfully applied for PET imaging of tumors [64] . Other chelates including diaminedithiols, activated mercaptoacetylglycylglycylgylcine (MAG 3 
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VEGF2 receptor Cyclo-(DFPQIMRIKPHQGQHIGE) [55] Tumor angiogenesis [56] Anti-HER2 antibody (AHNP) Human Epidermal Growth Factor Receptor 2 (HER2) FCDGFYACYKDV Breast cancer, ovarian cancer, gastric cancer [57] In terms of 18 F labeling for PET imaging, a prosthetic group such as N-succinimidyl-4-18 F-fluorobenzoate( 18 F-SFB) is essential for direct 18 F labeling of peptide [67] . Other chelates, such as 1,4,7-triazacyclononane-1,4-diacetate (NODA), can be used for indirect 18 F labeling of peptide (e.g., Al 18 F) [68] . Due to the short half-life of radionuclides, pep-NPs should be labeled and purified in a controlled and time-restricted manner: reliable, robust, and high throughput [58] .
Combining the advantages of "click reaction" and pepNPs, Liang and coworkers designed a protease-triggered self-assembly of radioactive nanoparticle ( 125 I-NPs), and proved that 125 I-NPs help the retention of radionuclide in living cancer cells. If the radionuclide 125 I is replaced with one of the radioisotopes 123 I, 124 I, or 131 I, this system could be applied for tumor imaging. Protein convertase furin is a trans-Golgi protease that preferentially cleaves R-X-K/R-R-X at . After entering the cancer cells, the designed compound, Acetyl-R-V-R-R-C(StBu)-Y( 125 I)-CBT (1), will firstly be reduced by intracellular glutathione (GSH), subsequently cleaved by furin, resulting in the active intermediate 1-Core. Two 1-Cores condense quickly to form amphiphilic dimers (1-Dimer) which self-assemble into radioactive nanoparticles ( 125 I-NPs) intracellularly via -stacking (Fig. 8) [69] .
Particles for Optical Imaging
Fluorophore-Labeled Particles
Tagging a peptide with a fluorophore is a common strategy for designing imaging agents. Fluorophores with emission wavelengths ranging from 400 nm to 600 nm, such as 7-amino-4-methylcoumarin (AMC), fluorescein isothiocyanate (FITC), and 5-carboxytetramethylrhodamine (TAMRA), are widely used in optical cell imaging in vitro. However, autofluorescences of tissue components such as water, hemoglobin, and deoxyhemoglobin in the near-infrared (NIR) region (650nm-900nm) hamper these probes for in vivo imaging. Recently, Liang and coworkers reported a strategy of self-assembling nanoparticles for optical imaging using a protease-controlled condensation reaction they developed. Caspase-3, which targets specific peptide sequence DEVD (Asp-Glu-Val-Asp), plays a key role in cell apoptosis [70] . Briefly, they fused the targeted peptide DEVD with the two reactive groups for condensation reaction (i.e., cyano group on benzothiazole motif and 1,2-aminothiol group on cysteine motif), conjugated a biotin motif for capturing FITC-labeled streptavidin (SA-FITC), and got the designed compound Acetyl-Asp-Glu-Val-Asp-Cys(StBu)-Lys(Biotin)-CBT (2) (Fig. 9) . When compound 2 is exposed to Caspase-3, the DEVD peptide sequence would be cleaved exposing the 1,2-aminothiol group which condenses with the cyano group on another molecule to form the dimer (1-D). At pH of 7.4, the dimer self-assembles to form biotinylated nanoparticles (Biotin-NPs) with diameters ranging from 100 nm to 300 nm. The Biotin-NPs can capture SA-FITC and induce a 2-fold enhancement of fluorescence, comparing with that SA-FITC in the solution of the scrambled control of 2 which is not susceptive to caspase-3 [71] .
Fluorophore-Quencher-Labeled Particles
Another strategy for designing fluorescence probes is using fluorophore-quencher-labeled pep-NPs to response to certain biological events such as the overexpression of certain proteases at specific sites, pH or thermal changes, etc. Briefly, the fluorophore and its quencher are conjugated to the same pep-NP so that the distance between the fluorophore and quencher is short enough for the quencher to efficiently quench the fluorescence of the fluorophore. When applied to certain biological events, the distance between the fluorophore and the quencher responses accordingly (normally increases) and subsequently the fluorophore is "lighted up". In this way, the pep-NPs can efficiently indicate the change of biological conditions. One common strategy is to use protease-specific peptide sequence as the linker between the quencher and the fluorophore. For instance, Myung and coworkers conjugated the NIR Dye Cy5.5 with its quencher BHQ-3 through a MMP-7 specific peptide substrate. After intratumoral injection of the conjugate, MMPs from the tumor cleaved peptide substrate and thereafter the fluorophore Cy5.5 was lighted up, thus the tumors were imaged under NIR [72] .
Particles for Magnetic Resonance Imaging(MRI)
MRI allows noninvasive tomographic visualization of anatomic structures and soft tissue with high spatial resolution and contrast. The limitation of MRI lies in the lack of sensitivity and detection accuracy in depicting the biochemical expression. Use of ultrasensitive methods accompanied with efficient contrast agents could compensate these disadvantages and achieve tumor-targeted imaging with high contrast. Gao and coworkers reported the design of superparamagnetic polymeric micelles (SPPM) and conjugated SPPM with PEG-PLA copolymer and cRGD ligand for targeting receptors on tumor cells. The off-resonance saturation (ORS) method, which applies a presaturation pulse at the off-resonance frequency position away from the bulk water, was used to detect picomolar concentrations of SPPM in vitro with higher image reproducibility than that in T 2 *-weighted method. The in vivo experiments showed that the ORS method could significantly increase the contrast sensitivity and detection accuracy of SPPM particles. And the SPPM particles exhibited a prolonged blood circulation half-life [73] . 
Particles for Raman Spectroscopy
Raman spectroscopy shows excellent sensitivity to small structural or chemical changes, resistance to autofluorescence and photobleaching, and require minimal sample preparation. However, the inherent weak signal on Raman spectrum limits its in vivo applications and this calls for new materials with effective enhancement of Raman peak for clinical use. Gambhir and coworkers reported using single wall nanotubes (SWNTs) conjugated with tumor-targeted peptides via PEG linkers for effective tumor imaging with Raman signal. This type of SWNTs conjugates exhibited a clear localization in tumor and a relatively longer in vivo circulation time than that of naked SWNTs [74] . Through the detection of the G-band on Raman spectrum, which is unique to SWNTs, the tumor sites could be easily located.
Particles for Multimodal Imaging
One paradox lies in molecular imaging is that modalities of higher sensitivities have relatively poorer resolutions or vice versa [75] . In 1998, the first fused PET/CT instrument was developed. Nowadays, there exists almost no standalone PET instrument. In the next wave of innovation, PET/MRIfused instruments have generated much hope for improving patients' safety and imaging capability over PET/CT [75] . Optical imaging, such as NIR, is highly sensitive but its applications in vivo are limited by its poor penetration ability in tissue and lack of anatomic resolution and spatial information. When combined with MRI which provides better performance on tomography and 3D imaging, a better diagnosis based on optical imaging could be conducted [76] . Due to high surface area and accessibility for modification, pep-NPs have been considered as promising vehicles for multimodality imaging. Multifunctional peptide-based nanoprobes have been developed for multimodality imaging to conquer the limitation of imaging with single modality. For instance, coated with major histocompatibility complex (MHC) peptide which specifically binds to the receptors on T cells, and PEG conjugated with fluorophores, the iron oxide nanoparticles could be used as dual functional contrast agents for MRI and optical imaging of cytotoxic T lymphocytes (CTLs) [77] .
For multimodal imaging, one important issue is to conjugate different contrast agents on one single nanoparticle. This would not only require more industrious work but also need more delicate design of the nanoparticles so that their cellular uptake performance would not be seriously weakened. For pep-NPs, one common reason for their failure of biological applications is that too many conjugates on the peptides hinder the peptides from accessing to their biological targets. Piwnica-Worms and coworkers used HIV-1 Tat basic domain peptides (Tat pep) to conjugate fluorescein-5-maleimide (FM) on the C-terminus and chelate [ 99m Tc(CO) 3 ] via histidine coordination on N-terminus. They used the dual-labeled probes for radiometric analysis and fluorescence imaging of tissues/organs. The in vivo experiments indicated that that the cell uptake for Tat pep is independent from both ends but influenced by the chelation cores. Thus, these probes could be cumulated within cells and provide qualitative and quantitative information at the target sites [78] .
Pep-NPs for Cancer Therapy
Introduction
To successfully deliver therapeutic agents to tumor in vivo, problems of drug resistance at cellular level, distribution, biotransformation, and clearance of the anticancer drugs from the body should be resolved [79] . Therefore, an ideal anticancer drug would have these features of being easily delivered to the tumor site, highly uptaken by cancer cells, resistant to cellular metabolism (excluding those pro-drugs), and highly cytotoxic to cancer cells.
Small molecules usually have difficulties in precisely targeting protein interactions for the reasons that protein interfaces are normally extensive, shallow, and hydrophobic in nature [80] . Therapeutics based on antibodies which show high affinities and specificities to tumors still have disadvantages such as unfavorable immunogenicity, low drug penetration, and undesired hypersensitivity reactions [81] . Nanoparticle-based drug delivery systems have been widely explored for cancer chemotherapies in recent decades. Those nanoparticles include polymeric micelles, liposomes, albumin-bound nanoparticles, etc [82] . Nevertheless, these systems usually face with the problems of cytotoxicity, non-specificity, and low efficiency in drug release. Compared with those materials used in above-mentioned methods, pep-NPs have extensive, specific, and highly affinitive interactions with proteins. Should the self-assembly of pep-NPs take in cancer cells, the peptide monomer is superior to antibody in delivering anticancer drugs to the target. Recently, some pep-NPs are reported to stabilize hydrophobic anticancer agents, such as ellipticine (EPT) [83] , pDNA [84] , and siRNA [85] . Moreover, some peptides which have high binding affinities to some cancer biomarkers are ideal anticancer drugs themselves. The real challenges for these types of peptides are efficient delivery to the targets and high cellular uptake.
Pep-NPs for Mimicking Natural Sequence to Mask Active Sites of Targeted Protein
There are pep-NPs reported to mediate protein behavior through masking the active sites of the targeted protein. For instance, signal transducer and activator of transcription (STAT) proteins are latent cytoplasmic transcription factor proteins which regulate cellular processes such as proliferation, differentiation and survival [86] . STAT5b, which is able to control cell survival and death, arrest cell cycle by regulating gene expression [87] , could be activated by phosphorylated Y845 kinase domain of EGFR in EGF stimulated tumor. Inhibition of STAT5b will induce cell apoptosis and cell proliferation arrested.
Inspired by this mechanism, Huang and coworkers designed a delivery system using liposome to encapsulate the negatively charged peptide, EEEEpYFELV (EV peptide) which mimics the Y845 site of EGFR, to block the phosphorylation of STAT5b so as to induce tumor cell apoptosis (Fig. 10a) . With EV peptides being encapsulated inside, surfaces of Liposome-protamince-heparin (LPH) nanoparticles were modified with PEG chains containing anisamide (PEG-AA) at the distal end to target the sigma receptors overexpressed in H460 human lung cancer cells (Fig. 10b) . MTT assay indicated that there was approximately 45% decrease of cell viability for H460 cells induced by LPH-PEG-AA EV, compared with that of LPH-PEG EV. Moreover, the dose-responsive inhibition study of the phosphorylation of STAT5b by EV delivered by LPH-PEG-AA indicated that EV specifically inhibits STAT5b at a concentration as low as 4 μM. Ex vivo biodistribution of the fluorescence-labeled EV peptide encapsulated by LPH indicated that it has the highest distribution in tumors and comparatively lower distribution in liver, suggesting its good selectivity of tumor-targeting (Fig. 10c) [88] . 
Pep-NPs for Protein/Peptide Therapy
Protein therapy [89] , replacing the dysfunctional proteins with new proteins artificially delivered, is the most direct method for cancer therapy. Its therapeutic efficacy is limited by low delivery efficiency and poor stability of the exotic proteins against the proteases inside cells.
Protein/peptide particles are mostly constructed with one single-protein core as drug or imaging agent and a shell covalently anchored to the core for achieving high efficiency of delivery while maintaining low cytotoxicity (e.g., liposomes [90, 91] , and cell-penetrating peptides (CPPs) [92] ). Other polymeric, biodegradable, natural products such as chitosans were also optimized and employed as shells to encapsulate the immunogenic protein/peptide cores to reduce their immunogenicities for cancer therapy [93] .
Lu and coworkers recently reported a novel intracellular protein delivery platform based on single-protein nanocapsules. They covalently linked polymerizable vinyl groups to the protein core. Subsequent polymerization of the vinyl groups with the free monomers in aqueous solution formed degradable or non-degradable cross-linked thin polymer skins over the protein core. Surface charge of the protein nanocapsules was able to be precisely controlled by appropriate choice of the monomers, such as cationic or neutral monomers. They proved that this strategy has two to three orders higher of cell transduction efficiency, more highly increased ability of the shell to protect protein core from proteolysis than those of nanocapsules conjugated with CPPs. The EGFP nanocapsules also exhibited increased in vivo stability than that of naked EGFP. Moreover, aciddegradable nanocapsules which decompose under a pH value lower than 5.5, acidity of late endosomes, were developed to allow the proteins accessible to intracellular biomacromolecules. Respective incubation of HeLa cells with native CAS (caspase-3), nCAS (non-degradable CAS nanocapsule), de-nCAS (degradable CAS nanocapsule), nBSA, and denBSA showed that there was an obvious decrease of cell proliferation in de-nCAS-treated group while the other groups exhibited similar, significant cell viabilities [94] .
Peptide vaccine, inducing and enhancing immune responses, is another widely utilized peptide-based therapy. In 2009, Cruz and coworkers reported an "anti-self" immunity vaccine to LHRH, which is used to achieve androgen deprivation as a treatment of prostate cancer. They conjugated FITC-peptide antigen to AuNPs (or encapsulated them in lipsome) modified with Fc peptide (targeting receptor for the lgG Fc fragments). These nanoparticles target DCs (dendritic cells) and consequently induce both primary and secondary immune responses. They successfully proved that this system has better performance for antigen uptake and doubling the immunological response than that of free antigen [95] .
Cell-Penetrating Peptides
Firstly discovered in 1965, cell-penetrating peptides (CPPs), natural peptides which are able to be uptaken by live cells, have similar properties to those of macromolecular carriers and celluar entry enhancers but with different mechanisms. Over the past 20 years, more than 100 peptidic sequences have been reported that are capable of internalizing into cells to mediate the transportation of a variety of biologically active molecules, cargos and drug delivery vectors [96] . A lot of review or research articles relating to CPPs on their basic features [97] , developing strategies [98] , and mechanisms [99] have been reported.
Ren and coworkers tagged a 6 amino acid peptide (A1, high affinity for VEGFR1) to TAT, the firstly discovered and most widely used CPP, as carriers for delivering siRNA to cancer cells for cancer therapy. Compared with other carriers at same dosage, CPPs do not exhibit cytotoxicity and are not resisted by any cell lines. Due to lacking of the selectivity for transferring the cargo to the destination, TAT was firstly conjugated with a tumor-targeting warhead A1 and then packed with siRNA to form aggregates or nanoparticles. HepG2 cells treated with this delivery system showed a 44% decrease of mRNA expression, compared with the control group [100] .
Using Physical Methods to Synthesize Pep-NPs for Drug Delivery
Physical methods have been employed to synthesize nanoparticles for a long time. Pep-NPs containing anticancer drugs could also be prepared with these physical methods including electronic/magnetic interactions, radiations, etc.
Clark and coworkers used electrospraying to prepare pH responsive, elastin-like polypeptide nanoparticles containing doxorubicin (DOX), a cancer chemotherapeutic, as a potential drug delivery system for cancer therapy. The peptides they used are recombinant elastin-like polypeptides (ELPs) which are derived from a penta-peptide Val-Pro-Gly-XaaGly (VPGXG) repeat in the amino acid sequence of human tropoelastin. ELPs are able to undergo a thermodynamically driven inverse phase transition which results in the release of DOX in the physiological condition. Briefly, they filled a syringe with the mixed solutions of ELP and DOX, pumped the solutions out under certain electric fields and at a set flow rate thus to get a dispersion of ELP nanoparticles. After the optimizations of the molecular weight for ELP, concentration of the solution, the ratio of drug to polymer, and spraying voltage, they obtained nanoparticles with diameters ranging from 150 nm to 570 nm and drug loading efficiency of 20 w/w % (Fig. 11) . Moreover, they proved a pH-dependent and ELP-transition-temperature-dependent release of DOX from the nanoparticles [101] . (vinylidene fluoride) (PVDF) as the stabilizer to crosslink poly-(acrylic acid) (PAA) to improve the hydrophilicity of the nanoparticles using electron-beam irradiation. Subsequently, the VEGFR-2 analogue, a cycle-peptide, CBO-P11, was covalently conjugated to the block copolymer through the click reaction between azide and alkyne. The pep-NPs could bind to VEGFR-2 receptor and functionalize as an attractive option for anticancer therapy [102] .
SUMMARY
In summary, pep-NPs have several advantages against other nanomaterials due to their inherent properties such as biocompatibility and biodegradability for cancer diagnosis and therapy. However, there still exist bottlenecks for pepNPs for above purposes. Firstly, there is a need for deep understanding of intermolecular and intramolecular interactions among the peptides so as to preserve their biological properties during the fabrication of pep-NPs. Secondly, limited number of mature enzymes or biomarker tags that could be targeted with high efficiency and specificity restricts the development of pep-NPs for a wide range of cancer cell lines. Lastly, design of pep-NPs in order to cater to the individually-based, non-invasive oriented, multimodality diagnosis and therapy of cancer needs to be optimized.
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